Sign Up to like & get
recommendations!
1
Published in 2022 at "Science Advances"
DOI: 10.1126/sciadv.abm7833
Abstract: Subunit vaccines inducing antibodies against tumor-specific antigens have yet to be clinically successful. Here, we use a supramolecular α-helical peptide nanofiber approach to design epitope-specific vaccines raising simultaneous B cell, CD8+ T cell, and CD4+…
read more here.
Keywords:
cell;
supramolecular peptide;
antitumor;
multiepitope supramolecular ... See more keywords